For 125 years, Isaac Wistar's vision and legacy have enabled The Wistar Institute to continue
its groundbreaking research aimed at improving the health of all mankind.
«This
groundbreaking study sets the stage for more exacting
research, using the latest genomic technologies and
aimed at developing new therapies that could help the tens of thousand of patients who urgently need our help,» said Dr. Nhan Tran, an Associate Professor of TGen's Cancer and Cell Biology Division and the study's other co-senior author.